Vivo Capital, LLC Compass Therapeutics, Inc. Transaction History
Vivo Capital, LLC
- $368 Million
- Q1 2025
A detailed history of Vivo Capital, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 3,556,023 shares of CMPX stock, worth $10.9 Million. This represents 1.83% of its overall portfolio holdings.
Number of Shares
3,556,023
Previous 3,556,023
-0.0%
Holding current value
$10.9 Million
Previous $5.16 Million
31.03%
% of portfolio
1.83%
Previous 1.01%
Shares
3 transactions
Others Institutions Holding CMPX
# of Institutions
123Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$68.7 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$33.9 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$30.8 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$25.9 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$20.3 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $311M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...